Journal of Genetic Counseling

, Volume 23, Issue 4, pp 689–692 | Cite as

Genomic Counseling: Next Generation Counseling

  • Rachel MillsEmail author
  • Susanne B. Haga
Professional Issues


Personalized medicine continues to expand with the development and increasing use of genome-based testing. While these advances present new opportunities for diagnosis and risk assessment, they also present challenges to clinical delivery. Genetic counselors will play an important role in ushering in this new era of testing; however, it will warrant a shift from traditional genetic counseling to “genomic counseling.” This shift will be marked by a move from reactive genetic testing for diagnosis of primarily single-gene diseases to proactive genome-based testing for multiple complex diseases for the purpose of disease prevention. It will also require discussion of risk information for a number of diseases, some of which may have low relative risks or weak associations, and thus, may not substantially impact clinical care. Additionally, genomic counselors will expand their roles, particularly in the area of health promotion to reduce disease risk. This additional role will require a style of counseling that is more directive than traditional counseling and require greater knowledge about risk reducing behaviors and disease screening.


Genomic counseling Genome-based testing Practice development Genomics Whole genome sequencing Direct-to-consumer testing 



This work was supported by the US National Institutes of Health (1R2HL096573-01A1). We thank Ms. Jennifer Sullivan for her thoughtful comments on previous drafts of the manuscript.


  1. Amrhein, P. C., Miller, W. R., Yahne, C. E., Palmer, M., & Fulcher, L. (2003). Client commitment language during motivational interviewing predicts drug use outcomes. Journal of Consulting and Clinical Psychology, 71(5), 12.CrossRefGoogle Scholar
  2. Ashley, E. A., Butte, A. J., Wheeler, M. T., Chen, R., Klein, T. E., Dewey, F. E., et al. (2010). Clinical assessment incorporating a personal genome. Lancet, 375(9725), 1525–1535.CrossRefGoogle Scholar
  3. Baker, D. L., Schuette, J. L., & Uhlmann, W. R. (1998). A guide to genetic counseling. New York: Wiley-Liss.Google Scholar
  4. Battista, R. N., Blancquaert, I., Laberge, A. M., van Schendel, N., & Leduc, N. (2012). Genetics in health care: an overview of current and emerging models. Public health genomics, 15(1), 34–45.CrossRefGoogle Scholar
  5. Biesecker, B. B. (2001). Goals of genetic counseling. Clinical genetics, 60(5), 323–330.CrossRefGoogle Scholar
  6. Bloss, C. S., Schork, N. J., & Topol, E. J. (2011). Effect of direct-to-consumer genomewide profiling to assess disease risk. The New England journal of medicine, 364(6), 524–534.CrossRefGoogle Scholar
  7. Chan, I. S., & Ginsburg, G. S. (2011). Personalized medicine: progress and promise. Annual review of genomics and human genetics, 12, 217–244.CrossRefGoogle Scholar
  8. Corpas, M. (2012). A family experience of personal genomics. Journal of genetic counseling, 21(3), 386–391.CrossRefGoogle Scholar
  9. Darst, B., Madlensky, L., Schork, N., Topol, E., Bloss, C. (2013). Perceptions of genetic counseling services in direct-to-consumer personal genomic testing. Clinical genetics.CrossRefGoogle Scholar
  10. Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I., Shuldiner, A. R., et al. (2006). TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. The New England journal of medicine, 355(3), 241–250.CrossRefGoogle Scholar
  11. Gettig, E. (2010). Commentary on genome-guided preventive medicine-new roles for genetic counselors. Journal of genetic counseling, 19(4), 328–329.CrossRefGoogle Scholar
  12. Gordon, E. S., Griffin, G., Wawak, L., Pang, H., Gollust, S. E., & Bernhardt, B. A. (2012). "It's Not Like Judgment Day": Public Understanding of and Reactions to Personalized Genomic Risk Information. Journal of genetic counseling, 21(3), 423–432.CrossRefGoogle Scholar
  13. Haga, S. B. (2009). Ethical issues of predictive genetic testing for diabetes. Journal of diabetes science and technology, 3(4), 781–788.CrossRefGoogle Scholar
  14. Haga, S. B., Burke, W., Ginsburg, G. S., Mills, R., & Agans, R. (2012). Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clinical genetics, 82(4), 388–394.CrossRefGoogle Scholar
  15. Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genetics in medicine : official journal of the American College of Medical Genetics, 10(1), 19–32.CrossRefGoogle Scholar
  16. Hettema, J., Steele, J., & Miller, W. R. (2005). Motivational interviewing. Annu Rev Clin Psychol, 1, 91–111.CrossRefGoogle Scholar
  17. Hofman, K. J., Tambor, E. S., Chase, G. A., Geller, G., Faden, R. R., & Holtzman, N. A. (1993). Physicians' knowledge of genetics and genetic tests. Academic medicine : journal of the Association of American Medical Colleges, 68(8), 625–632.CrossRefGoogle Scholar
  18. Hunter, A., Wright, P., Cappelli, M., Kasaboski, A., & Surh, L. (1998). Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients. Clinical genetics, 53(6), 447–455.CrossRefGoogle Scholar
  19. Levin, E., Riordan, S., Klein, J., & Kieran, S. (2012). Genetic counseling for personal genomic testing: optimizing client uptake of post-test telephonic counseling services. Journal of genetic counseling, 21(3), 462–468.CrossRefGoogle Scholar
  20. Markowitz, S. M., Park, E. R., Delahanty, L. M., O'Brien, K. E., & Grant, R. W. (2011). Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes. Diabetes care, 34(3), 568–573.CrossRefGoogle Scholar
  21. Marteau, T. M., French, D. P., Griffin, S. J., Prevost, A. T., Sutton, S., Watkinson, C., et al. (2010). Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev, 10, CD007275.Google Scholar
  22. Marteau, T. M., & Lerman, C. (2001). Genetic risk and behavioural change. BMJ, 322(7293), 1056–1059.CrossRefGoogle Scholar
  23. Mattei, J., Qi, Q., Hu, F. B., Sacks, F. M., & Qi, L. (2012). TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. The American journal of clinical nutrition, 96(5), 1129–1136.CrossRefGoogle Scholar
  24. McCaffery, J. M., Jablonski, K. A., Franks, P. W., Dagogo-Jack, S., Wing, R. R., Knowler, W. C., et al. (2011). TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. PloS one, 6(7), e21518.CrossRefGoogle Scholar
  25. Middleton, A. (2012). Communication about DTC testing: commentary on a 'family experience of personal genomics'. Journal of genetic counseling, 21(3), 392–398.CrossRefGoogle Scholar
  26. NSGC (2012). National Society of Genetic Counselors: 2012 Professional Status Survey.
  27. O'Daniel, J. M. (2010). The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors. Journal of genetic counseling, 19(4), 315–327.CrossRefGoogle Scholar
  28. Ormond, K. E., Wheeler, M. T., Hudgins, L., Klein, T. E., Butte, A. J., Altman, R. B., et al. (2010). Challenges in the clinical application of whole-genome sequencing. Lancet, 375(9727), 1749–1751.CrossRefGoogle Scholar
  29. Patel, C. J., Sivadas, A., Tabassum, R., Preeprem, T., Zhao, J., Arafat, D., et al. (2013). Whole Genome Sequencing in support of Wellness and Health Maintenance. Genome medicine, 5(6), 58.CrossRefGoogle Scholar
  30. Pengchit, W., Walters, S. T., Simmons, R. G., Kohlmann, W., Burt, R. W., Schwartz, M. D., et al. (2011). Motivation-based intervention to promote colonoscopy screening: an integration of a fear management model and motivational interviewing. Journal of health psychology, 16(8), 1187–1197.CrossRefGoogle Scholar
  31. Peter, I., McCaffery, J. M., Kelley-Hedgepeth, A., Hakonarson, H., Reis, S., Wagenknecht, L. E., et al. (2012). Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial. Obesity, 20(8), 1675–1682.CrossRefGoogle Scholar
  32. Phimister, E. G., Feero, W. G., & Guttmacher, A. E. (2012). Realizing genomic medicine. The New England journal of medicine, 366(8), 757–759.CrossRefGoogle Scholar
  33. Pierce, M., Ridout, D., Harding, D., Keen, H., & Bradley, C. (2000). More good than harm: a randomised controlled trial of the effect of education about familial risk of diabetes on psychological outcomes. Br J Gen Pract, 50(460), 867–871.PubMedPubMedCentralGoogle Scholar
  34. Riordan, S., Rodriguez, D. F., Kieran, S. (2012). Personal Genomic Testing as Part of the Complete Breast Cancer Risk Assessment: A Case Report. Journal of genetic counseling.Google Scholar
  35. Roberts, M. E., Riegert-Johnson, D. L., & Thomas, B. C. (2011). Self diagnosis of Lynch syndrome using direct to consumer genetic testing: a case study. Journal of genetic counseling, 20(4), 327–329.CrossRefGoogle Scholar
  36. Scheuner, M. T., Sieverding, P., & Shekelle, P. G. (2008). Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA : the journal of the American Medical Association, 299(11), 1320–1334.CrossRefGoogle Scholar
  37. Sharp, R. R. (2011). Downsizing genomic medicine: approaching the ethical complexity of whole-genome sequencing by starting small. Genetics in medicine : official journal of the American College of Medical Genetics, 13(3), 191–194.CrossRefGoogle Scholar
  38. Sturm, A. C., Manickam, K. (2012). Direct-to-Consumer Personal Genomic Testing: A Case Study and Practical Recommendations for "Genomic Counseling". Journal of genetic counseling.Google Scholar
  39. Waxler, J. L., O'Brien, K. E., Delahanty, L. M., Meigs, J. B., Florez, J. C., Park, E. R. et al. (2012) Genetic Counseling as a Tool for Type 2 Diabetes Prevention: A Genetic Counseling Framework for Common Polygenetic Disorders. Journal of genetic counseling.Google Scholar
  40. Zhang, X., Qi, Q., Zhang, C., Smith, S. R., Hu, F. B., Sacks, F. M., et al. (2012). FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes, 61(11), 3005–3011.CrossRefGoogle Scholar

Copyright information

© National Society of Genetic Counselors, Inc. 2013

Authors and Affiliations

  1. 1.Institute for Genome Sciences & PolicyDuke UniversityDurhamUSA

Personalised recommendations